Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 3/24/20 → 1/11/24 |
Funding
- Medpace Inc: $90,095.00
An Open-Label, Randomised, Multicentre, Phase III Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Leucovorin Versus Nab-paclitaxel Plus Gemcitabine in Subjects Who Have Not Previously Received Chemotherapy for Metastatica
- Patel, Reema (PI)